(Q34670638)

3 August 2017

title

Circulating angiogenic and antiangiogenic factors in women with eclampsia (English)

1 reference

3 August 2017

0 references

angiogenesis inhibitor

1 reference

Edi Vaisbuch

1

0 references

Yoram Sorokin

series ordinal

7

object named as

Yoram Sorokin

1 reference

3 August 2017

Roberto Romero

4

0 references

S Ananth Karumanchi

series ordinal

8

object named as

S Ananth Karumanchi

1 reference

3 August 2017

3

Sonia S Hassan

1 reference

3 August 2017

6

David B Cotton

1 reference

3 August 2017

5

Juan Pedro Kusanovic

1 reference

3 August 2017

Janice E Whitty

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

9 November 2010

1 reference

American Journal of Obstetrics and Gynecology

3 August 2017

published in

1 reference

3 August 2017

volume

204

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

152.e1-9

1 reference

The perinatal implications of angiogenic factors

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia--a step forward but not the definitive answer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Maternal circulating levels of activin A, inhibin A, sFlt-1 and endoglin at parturition in normal pregnancy and pre-eclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Preeclampsia and angiogenic imbalance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Second-trimester angiogenic factors as biomarkers for future-onset preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Molecular mechanisms of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Soluble endoglin contributes to the pathogenesis of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Recent advances in understanding of preeclampsia.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Latest advances in understanding preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Soluble Fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Circulating angiogenic factors in preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Diagnosis, prevention, and management of eclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

A longitudinal study of biochemical variables in women at risk of preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Vascular endothelial growth factor is increased in patients with preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Eclampsia in the United Kingdom.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Neonatal outcome after preterm delivery for preeclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Active management of the unconscious eclamptic patient

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Main clinical types and subtypes of eclampsia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Trends in maternal mortality in a tertiary institution in Northern Nigeria

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Prenatal medicine: the child is the father of the man. 1996.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

The great obstetrical syndromes.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Soluble endoglin as a second-trimester marker for preeclampsia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Analysis of placental growth factor in placentas of normal pregnant women and women with hypertensive disorders of pregnancy.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Low urinary placental growth factor is a marker of pre-eclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Report of 50 cases of eclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Circulating angiogenic factors and the risk of preeclampsia

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Late postpartum eclampsia: a preventable disease?

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Preeclampsia into eclampsia: toward a new paradigm

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Eclampsia. VIII. Risk factors for maternal morbidity

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Preeclampsia may cause both overperfusion and underperfusion of the brain: a cerebral perfusion based model

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3057127

A United States national reference for fetal growth

9 December 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Preeclampsia is associated with reduced serum levels of placenta growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/21062661

1 reference

12 December 2020

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Angiogenic factors and preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Angiogenic factors for the prediction of preeclampsia in high-risk women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Cerebral edema complicating eclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Placenta growth factor is not an early marker for the development of severe preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Decreased maternal serum placenta growth factor in early second trimester and preeclampsia

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Plasma placenta growth factor levels in midtrimester pregnancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Cerebral infarction in eclampsia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986

1 reference

https://pubmed.ncbi.nlm.nih.gov/21062661

12 December 2020

10.1016/J.AJOG.2010.08.049

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference